Is There a Cheaper Version of Mounjaro — and Is It Safe?

You've seen big price differences between providers, here's what's actually going on

You've probably noticed prices for Mounjaro that vary quite a bit across UK providers. That variation is real, but it rarely reflects what you think it does. The medicine inside the pen is identical regardless of where a legitimate pharmacy sources it, Eli Lilly's UK-licensed product, through the authorised supply chain. What differs is what the price wraps around the medicine.

In terms of the underlying cost of the product itself, it's worth knowing that Eli Lilly raised Mounjaro's UK list price substantially from 1 September 2025. The highest dose's list price rose from around £122 to around £330 per four-week pen, as widely reported at the time. Private treatment prices since then have typically ranged roughly £149–£375 per month depending on the dose and the provider. Those figures are a useful frame of reference, but they are market figures, not what any individual will necessarily pay.

If a price sits well below that range, the question worth asking is not "why is this cheaper?" but "what is missing?" Sometimes it is a consultation fee billed separately. Sometimes it is a prescription charge on top. Sometimes delivery is added at checkout. And sometimes the source of the medicine itself is the problem, which is where the real risk lives. You can read more about why Mounjaro sometimes appears cheaper in the UK and how UK private pricing is structured on our Mounjaro price guide.

What headline prices often quietly leave out

A low headline figure for Mounjaro tends to be a starting price rather than an ending one. The costs that can appear separately include a consultation fee (often £20–£50), a prescription charge, a delivery fee, and aftercare or dose-review support billed as an extra each month. Taken together, those additions can close (or reverse) any gap between a cheap-looking listing and a more transparent all-in price.

There is also the question of what happens when something goes wrong or when you need a dose increase. Clinical re-review before every repeat is not a given across providers; some rely on automated questionnaires with no prescriber reading the answers. The NICE appraisal of tirzepatide, TA1026, underlines that appropriate oversight matters throughout treatment, not just at the start.

At nume, one price covers consultation, prescription, the medicine, next-working-day delivery and ongoing aftercare. There are no add-ons and no subscription that continues unless you choose to reorder. We don't win a price comparison on the headline number, that's a deliberate choice. What you're paying for is a fully-staffed clinical pathway, not a fulfilment operation. A more detailed breakdown of what is and isn't included across the market is on our guide to getting Mounjaro more cheaply, including what to make of providers advertising a cheaper version of Mounjaro.

Why 'cheapest' is not the metric a prescription medicine deserves

Mounjaro is a Prescription-Only Medicine. UK law requires a clinical assessment before it can be prescribed, not as a formality, but because it has real contraindications, real interactions (including with oral contraceptives during the early weeks of treatment and after dose increases), and a side-effect profile that benefits from supervision. The NHS tirzepatide page sets out that profile clearly, including gastrointestinal effects and the signs that warrant prompt medical attention.

The MHRA has warned repeatedly about fake weight-loss pens sold online, including (as first reported in October 2023) counterfeit pens that contained insulin rather than the expected medicine, with hospitalisations resulting. Enforcement has continued: in 2025 around 20 million doses of illegally traded weight-loss medicines (roughly £45 million street value) were seized, and the first UK site manufacturing counterfeit tirzepatide pens was raided in Northampton. A price that looks too good to be true, from a seller you cannot verify on the GPhC register, is a genuine safety concern, not a bargain. This is particularly relevant if you have come across listings for cheap tirzepatide peptide, which typically refers to research-grade material that is not licensed for human use. You can verify any online pharmacy at the GPhC register; nume's registration is number 9012878.

The right question is not "where is this cheapest?" but "where is this genuinely safe, from a prescriber who has actually read my health history, via a verified pharmacy with a real supply chain?" That framing points somewhere different to a lowest-price search. If you want to explore where Mounjaro is cheapest while still meeting those safety standards, our page on where to buy Mounjaro at a fair price covers the landscape honestly.

What a legitimate private consultation with nume looks like

The process at nume is straightforward. You complete a free clinical consultation online; a named GPhC-registered Independent Prescriber reads it the same day. There is photo-ID verification, live weight confirmation on video, and a GP notification in line with GPhC guidance. If Mounjaro is clinically suitable, treatment is dispatched the same working day for orders placed before 12pm, arriving via tracked DPD the next working day in plain, unbranded packaging.

Your pen goes straight in the fridge when it arrives (between 2–8°C, as detailed in the Patient Information Leaflet) and that's genuinely the last logistical thought until your next order. Before every repeat, a prescriber reviews your case again. No auto-renewal, no assumption that what suited you at 5mg still suits you at 10mg.

We don't claim to be the cheapest option, and we're not. What we offer is a clinical service that treats Mounjaro as the prescription medicine it is, not a product to shift. If you want to understand what clinical suitability actually involves, our Mounjaro overview covers the eligibility criteria in full. To take the first step, check your eligibility with a free consultation, no payment until you are clinically approved and choose to proceed.